Understanding clubfoot statistics in the UK helps parents, clinicians, and policymakers appreciate the scale of this condition and how effectively it's being managed. Clubfoot (congenital talipes equinovarus, or CTEV) is one of the most common musculoskeletal birth differences, and the UK has a strong track record of treatment outcomes since adopting the Ponseti method as the national standard.
Incidence and Prevalence
How Common Is Clubfoot?
Clubfoot occurs in approximately 1 in 1,000 live births in the UK. With roughly 620,000–650,000 births per year in England and Wales (ONS data), this means approximately 600–650 babies are born with clubfoot in England and Wales each year. Including Scotland and Northern Ireland, the UK-wide figure is approximately 700–750 new cases annually.
To put this in context:
- Clubfoot is approximately twice as common as cleft lip/palate (1 in 700 vs approximately 1 in 1,500)
- It is roughly as common as Down's syndrome in terms of birth prevalence
- It is significantly more common than many conditions that receive more public attention, such as cystic fibrosis (1 in 2,500) or spina bifida (1 in 1,000–2,000)
Sex Distribution
Clubfoot is approximately twice as common in boys as girls. The male-to-female ratio is roughly 2:1 to 2.5:1 across UK and international studies. The reason for this sex difference isn't fully understood but is thought to relate to hormonal influences on connective tissue development and sex-linked genetic factors. Read more about the genetic basis in our genetics guide.
Bilateral vs Unilateral
Approximately 50% of cases are bilateral (both feet affected) and 50% are unilateral (one foot). When only one foot is affected, the right foot is slightly more commonly involved than the left, though the difference is small.
Ethnic and Regional Variation
Clubfoot incidence varies somewhat across ethnic groups:
- Polynesian populations — the highest recorded rates, approximately 6–7 per 1,000
- White European populations — approximately 1–1.2 per 1,000 (the UK average)
- East Asian populations — lower rates, approximately 0.5–0.6 per 1,000
- African populations — data is more variable, ranging from 0.5 to 2 per 1,000 depending on the study
Within the UK, there is no strong regional variation in incidence after adjusting for ethnic composition. Urban and rural areas report similar rates, as do different NHS regions.
Prenatal Detection Rates
The NHS Fetal Anomaly Screening Programme (FASP) includes the 20-week anomaly scan, which can sometimes detect clubfoot. UK-specific data on detection rates:
- Overall prenatal detection rate: approximately 60–80% of clubfoot cases are identified at the 20-week scan, though this varies significantly between centres
- Bilateral cases are more reliably detected than unilateral cases
- Isolated clubfoot (without other anomalies) is harder to detect than clubfoot associated with other visible findings
- Sensitivity has improved over the past decade as scanning technology and sonographer training have advanced
When clubfoot is detected prenatally, parents are typically offered a consultation with the orthopaedic team before birth. This allows for information sharing, treatment planning, and early referral.
Treatment Adoption: The Ponseti Shift
One of the most significant changes in UK clubfoot care over the past two decades has been the near-universal adoption of the Ponseti method as the primary treatment. The timeline:
- Before 2000: Most UK centres used surgical correction (posteromedial release) as the primary treatment. Success rates were approximately 50–70%, with significant rates of stiffness, pain, and need for repeat surgery
- 2000–2005: Early-adopter centres in the UK began transitioning to the Ponseti method, following evidence from North American and European studies showing superior outcomes
- 2005–2010: Rapid adoption across NHS trusts. The British Society for Children's Orthopaedic Surgery (BSCOS) endorsed Ponseti as the gold standard
- 2010–present: Effectively all NHS centres in the UK now use the Ponseti method as the first-line treatment. Surgical approaches are reserved for resistant cases or relapse management
This transition is reflected in outcome data: the UK's initial correction rate with Ponseti exceeds 95%, compared with the more variable outcomes seen with the older surgical approaches.
Treatment Outcomes: UK Data
Initial Correction
UK centres report initial correction rates (achieving a plantigrade foot through Ponseti casting and tenotomy) of 95–98% for idiopathic clubfoot. This is consistent with international benchmarks.
- Most children require 4–7 casts (average 5)
- Approximately 80–90% require an Achilles tenotomy
- Average treatment start age in the UK is 7–14 days of life
Relapse Rates
Relapse remains the most significant challenge in clubfoot management. UK data shows:
- Overall relapse rate: approximately 20–40% depending on the definition used and length of follow-up
- Relapse requiring repeat casting: approximately 15–25%
- Relapse requiring TATT surgery: approximately 10–20%
- Relapse requiring more extensive surgery: approximately 5%
The primary risk factor for relapse is non-compliance with bracing protocols. Studies consistently show that families who maintain brace wear as prescribed have significantly lower relapse rates.
Long-Term Functional Outcomes
Long-term follow-up data from UK centres shows:
- 90–95% of Ponseti-treated children walk without a noticeable limp
- 85–90% participate in sport without restriction (including competitive sport)
- 70–80% have good or excellent patient-reported outcomes in adulthood
- Calf size asymmetry persists in approximately 60–70% of unilateral cases but rarely causes functional limitation
- Ankle stiffness — mild reduction in ankle range of motion is present in approximately 30–50% of treated feet but is typically asymptomatic
NHS Service Provision
Specialist Centres
Clubfoot treatment on the NHS is delivered through paediatric orthopaedic departments, typically within children's hospitals or district general hospitals with paediatric orthopaedic consultants. Major centres include:
- Great Ormond Street Hospital — London
- Alder Hey Children's Hospital — Liverpool
- Sheffield Children's Hospital — Sheffield
- Birmingham Children's Hospital — Birmingham
- Royal Hospital for Children — Glasgow
- Noah's Ark Children's Hospital — Cardiff
- Royal Belfast Hospital for Sick Children — Belfast
In addition to these large centres, many district general hospitals provide excellent Ponseti treatment through specialist-trained physiotherapists or orthopaedic practitioners working under consultant supervision.
Workforce
Clubfoot treatment in the UK is delivered by a mix of:
- Paediatric orthopaedic consultants
- Specialist physiotherapists (Ponseti-trained)
- Orthopaedic nurse practitioners
- Orthotists (for bracing)
A notable UK innovation has been the physiotherapist-led Ponseti clinic, where trained physiotherapists perform the serial casting and monitoring under consultant supervision. This model has been shown to produce outcomes equivalent to consultant-led care while improving appointment availability and reducing waiting times.
Waiting Times
Clubfoot treatment typically begins within the first 1–2 weeks of life. NHS guidelines recommend that the first cast is applied by 2 weeks of age where possible. In practice, most centres achieve this — clubfoot is treated as urgent given the time-sensitive nature of early intervention.
Cost of Treatment
While NHS treatment is free at the point of delivery, the economic burden of clubfoot treatment has been studied:
- Direct NHS cost of Ponseti treatment (casting through bracing): approximately £2,000–£4,000 per child over the full treatment period
- Surgical correction (PMR) when it was the standard: approximately £5,000–£8,000 per child, with higher costs for revision procedures
- Cost-effectiveness: the Ponseti method is significantly more cost-effective than surgical approaches, saving the NHS an estimated £3,000–£5,000 per patient while producing better outcomes
- Indirect costs to families: time off work, travel to appointments, and additional childcare costs are not covered by the NHS. DLA claims can offset some of these costs
Research and Registries
The UK Clubfoot Consensus
In 2012, a UK-wide consensus was published establishing national guidelines for Ponseti treatment. This document, endorsed by BSCOS, standardised the treatment protocol across NHS trusts and has been regularly updated.
National Audit Data
There is no single national clubfoot registry in the UK (unlike, for example, joint replacement registries). However, several regional and national datasets contribute to our understanding of outcomes:
- The British Isles Congenital Anomaly Registers (BICAR) record clubfoot diagnoses but don't track treatment outcomes
- Individual hospital clinical databases track their own patients
- Research collaboratives such as the UK Clubfoot Study Group publish multi-centre outcome data
Active Research Areas
UK institutions are actively contributing to clubfoot research in several areas:
- Genetics: genome-wide association studies identifying risk genes
- Brace compliance: sensor-equipped braces that monitor actual wear time versus prescribed wear time
- 3D printing: custom braces produced by 3D scanning and printing technology
- Telemedicine: remote monitoring and virtual consultations, accelerated by the COVID-19 pandemic
- Long-term outcomes: 20+ year follow-up studies of the first UK Ponseti cohorts
Global Context
Globally, approximately 150,000–200,000 babies are born with clubfoot each year. While the UK and other high-income countries achieve correction rates above 95%, access to Ponseti treatment remains a challenge in low- and middle-income countries. Organisations such as MiracleFeet and the Global Clubfoot Initiative work to bring Ponseti training and equipment to underserved regions.
The UK has been a significant contributor to global clubfoot care through training programmes, research output, and charitable partnerships. British orthopaedic surgeons and physiotherapists have trained Ponseti practitioners in numerous countries across Africa, Asia, and South America.
Frequently Asked Questions
Q: How many babies are born with clubfoot in the UK each year?
A: Approximately 700–750, based on an incidence of 1 per 1,000 live births applied to current UK birth rates. This figure covers all four nations (England, Wales, Scotland, and Northern Ireland).
Q: Is clubfoot becoming more or less common?
A: The incidence of clubfoot has remained stable over time — approximately 1 per 1,000 births across decades of monitoring. What has changed dramatically is the treatment: the shift from surgical correction to the Ponseti method has transformed outcomes. Detection rates have improved due to better antenatal scanning, meaning more cases are identified before birth.
Q: What percentage of clubfoot cases are successfully treated?
A: Initial correction is achieved in 95–98% of idiopathic cases using the Ponseti method. Long-term success (defined as a functional, plantigrade foot without major surgery) is achieved in approximately 80–90% of patients when bracing compliance is good. The main barrier to long-term success is relapse related to brace non-compliance.
Q: Does the UK have a national clubfoot registry?
A: Not currently. Unlike hip dysplasia (which has a national screening programme) or joint replacements (which have a national registry), clubfoot doesn't have a UK-wide registry that tracks all cases from diagnosis through to long-term outcome. There have been calls for one, and some researchers are working towards establishing a more systematic national dataset.
Q: How does the UK compare internationally for clubfoot treatment?
A: The UK is among the world leaders in clubfoot treatment. With near-universal Ponseti adoption, a strong specialist workforce, free NHS access to treatment, and active research programmes, UK outcomes are on par with or better than most comparable countries. The main areas for improvement are more consistent prenatal detection rates and reducing relapse through better brace compliance support.